S64 An Update on PCSK9 Inhibitors

Program: Symposia
Bench to Bedside Session
Monday, April 4, 2016: 11:45 AM-1:15 PM
Room 160 (BCEC)
Chair:
Connie Newman, MD, NYU Langone Medical Center, New York, NY

Nothing to Disclose: CN
11:45 AM
Zahid Ahmad, MD, Internal Medicine, Division of Nutrition and Metabolic Disease, UT Southwestern Medical Center, Dallas, TX
Disclosures:
ZA: Advisory Group Member, Genzyme Corporation, Speaker, Sanofi, Speaker, Genzyme Corporation.
12:15 PM
Robert Harold Eckel, MD, Anschutz Medical Campus, University of Colorado, Aurora, CO
Disclosures:
RHE: Consultant, Amgen, Advisory Group Member, Pfizer, Inc., Advisory Group Member, Regeneron.
12:45 PM
Eliot A Brinton, MD, University of Utah School of Medicine, Salt Lake City, UT
Disclosures:
EAB: Ad Hoc Consultant, Alexion, Speaker, Jansen Pharmaceuticals, Speaker, Alexion, Speaker, Jansen Pharmaceuticals, Speaker, Astra Zeneca, Speaker, Merck & Co., Ad Hoc Consultant, Regeneron, Ad Hoc Consultant, Sanofi, Advisory Group Member, PTS Diagnostics, Speaker, Astra Zeneca, Speaker, Sanofi, Speaker, Takeda, Speaker, Alexion, Ad Hoc Consultant, Merck & Co., Ad Hoc Consultant, Astra Zeneca, Speaker, Kowa, Ad Hoc Consultant, Eli Lilly & Company, Ad Hoc Consultant, Novartis Pharmaceuticals, Ad Hoc Consultant, Amgen, Ad Hoc Consultant, Merck & Co., Ad Hoc Consultant, Eli Lilly & Company, Ad Hoc Consultant, Alexion, Speaker, Takeda, Speaker, Regeneron, Speaker, Merck & Co., Ad Hoc Consultant, Amarin, Ad Hoc Consultant, Alexion, Ad Hoc Consultant, Amgen, Speaker, Amarin, Ad Hoc Consultant, Amarin, Speaker, Alexion, Ad Hoc Consultant, Astra Zeneca, Speaker, Amarin, Ad Hoc Consultant, Amgen, Advisory Group Member, PTS Diagnostics, Advisory Group Member, PTS Diagnostics, Speaker, Astra Zeneca, Ad Hoc Consultant, Astra Zeneca, Ad Hoc Consultant, Sanofi, Ad Hoc Consultant, Eli Lilly & Company, Ad Hoc Consultant, Sanofi, Speaker, Sanofi, Speaker, Jansen Pharmaceuticals, Speaker, Astra Zeneca, Ad Hoc Consultant, Novartis Pharmaceuticals, Speaker, Sanofi, Ad Hoc Consultant, Merck & Co., Ad Hoc Consultant, Eli Lilly & Company, Speaker, Kowa, Speaker, Jansen Pharmaceuticals, Ad Hoc Consultant, Regeneron, Speaker, Merck & Co., Ad Hoc Consultant, Novartis Pharmaceuticals, Speaker, Regeneron, Ad Hoc Consultant, Merck & Co., Speaker, Takeda, Speaker, Kowa, Speaker, Merck & Co., Ad Hoc Consultant, Amarin, Ad Hoc Consultant, Regeneron, Speaker, Takeda, Speaker, Amarin, Advisory Group Member, PTS Diagnostics, Ad Hoc Consultant, Amarin, Speaker, Regeneron, Speaker, Amarin, Ad Hoc Consultant, Sanofi, Advisory Group Member, PTS Diagnostics, Speaker, Sanofi, Ad Hoc Consultant, Sanofi, Ad Hoc Consultant, Novartis Pharmaceuticals, Speaker, Sanofi, Speaker, Kowa, Ad Hoc Consultant, Novartis Pharmaceuticals, Ad Hoc Consultant, Regeneron, Speaker, Kowa, Speaker, Regeneron, Ad Hoc Consultant, Regeneron, Speaker, Regeneron.
See more of: Symposia

 

The Endocrine Society would like to thank the following organizations for their support: AbbVie Inc.; Bayer HealthCare Pharmaceuticals Inc.; Boehringer Ingelheim Pharmaceuticals, Inc.; Chiasma, Inc.; Corcept Therapeutics Incorporated; Eisai, Inc.; Ethicon Endo-Surgery, Inc.; Genzyme, a Sanofi company, Ipsen Biopharmaceuticals, Inc.; Leona M. and Harry B. Helmsley Charitable Trust; Lilly USA, LLC; Medtronic Diabetes; Merck & Co., Inc.; Novartis Pharmaceuticals Corporation; Novo Nordisk Inc.; Pfizer, Inc.; Shire